Esomeprazole Magnesium
NDC Package 45865-892-30
Package Information
Esomeprazole Magnesium is delayed-release capsules are contraindicated in patients with known hypersensitivity to substituted benzimidazoles or to any component of the formulation. Marketed by Medsourcer Pharmaceuticals, this product is identified by NDC 45865-892 and is authorized under FDA application ANDA205606.
Identification & Billing
- RxCUI: 606726 - esomeprazole magnesium 20 MG Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium dihydrate 22 MG) Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45865 - Medsourcer Pharmaceuticals
- 45865-892 - Esomeprazole Magnesium
- 45865-892-30 - 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE
- 45865-892 - Esomeprazole Magnesium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (45865-892). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45865-892-30 identifies a specific commercial package of 30 capsule, delayed release in 1 bottle of Esomeprazole Magnesium, labeled by Medsourcer Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medsourcer Pharmaceuticals on April 21, 2016. The current certification is valid through December 31, 2024.
How is this Medsourcer Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45865089230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.